Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination (MACS2226)
Sponsor: Novartis Pharmaceuticals
A observational or N/A phase clinical study on Gastrointestinal Stromal Tumor, this trial is ongoing. The trial is conducted by Novartis Pharmaceuticals and has accumulated 8 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
No Longer Available
-
Sep 2024 — Sep 2025 [monthly]
No Longer Available
-
Jul 2024 — Sep 2024 [monthly]
No Longer Available
-
Jan 2021 — Jul 2024 [monthly]
No Longer Available
-
Jun 2018 — Jan 2021 [monthly]
No Longer Available
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
No Longer Available
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
No Longer Available NA
Phase: PHASE4 → NA
-
Jan 2017 — Jul 2017 [monthly]
No Longer Available PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .